Complete remission with tyrosine kinase inhibitors in renal cell carcinoma. [electronic resource]
Producer: 20120330Description: 482-7 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Feasibility Studies
- Female
- Humans
- Indoles -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Male
- Medical Records
- Middle Aged
- Molecular Targeted Therapy
- Nephrectomy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyridines -- therapeutic use
- Pyrroles -- therapeutic use
- Remission Induction
- Retrospective Studies
- Sorafenib
- Sunitinib
- Surveys and Questionnaires
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.